STONERIDGE INC (SRI)

US86183P1021 - Common Stock

15.78  +0.43 (+2.8%)

After market: 15.78 0 (0%)

Fundamental Rating

3

SRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 42 industry peers in the Automobile Components industry. SRI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, SRI is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year SRI has reported negative net income.
SRI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SRI reported negative net income in multiple years.
SRI had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

SRI has a Return On Assets of -0.76%. This is in the lower half of the industry: SRI underperforms 61.90% of its industry peers.
SRI has a Return On Equity (-1.80%) which is comparable to the rest of the industry.
SRI has a Return On Invested Capital of 2.73%. This is in the lower half of the industry: SRI underperforms 64.29% of its industry peers.
Industry RankSector Rank
ROA -0.76%
ROE -1.8%
ROIC 2.73%
ROA(3y)-0.8%
ROA(5y)1.26%
ROE(3y)-1.88%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of SRI (1.78%) is worse than 66.67% of its industry peers.
In the last couple of years the Operating Margin of SRI has declined.
SRI's Gross Margin of 20.71% is fine compared to the rest of the industry. SRI outperforms 61.90% of its industry peers.
In the last couple of years the Gross Margin of SRI has declined.
Industry RankSector Rank
OM 1.78%
PM (TTM) N/A
GM 20.71%
OM growth 3YN/A
OM growth 5Y-25.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.77%
GM growth 5Y-6.92%

4

2. Health

2.1 Basic Checks

SRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SRI has more shares outstanding
SRI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SRI is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.02 indicates that SRI is not in any danger for bankruptcy at the moment.
SRI has a Altman-Z score of 3.02. This is in the better half of the industry: SRI outperforms 71.43% of its industry peers.
SRI has a Debt/Equity ratio of 0.66. This is a neutral value indicating SRI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, SRI is doing worse than 69.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC0.24
WACC11.41%

2.3 Liquidity

A Current Ratio of 2.41 indicates that SRI has no problem at all paying its short term obligations.
SRI has a Current ratio of 2.41. This is in the better half of the industry: SRI outperforms 66.67% of its industry peers.
A Quick Ratio of 1.36 indicates that SRI should not have too much problems paying its short term obligations.
SRI has a Quick ratio of 1.36. This is in the better half of the industry: SRI outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.36

4

3. Growth

3.1 Past

SRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.67%, which is quite impressive.
Looking at the last year, SRI shows a quite strong growth in Revenue. The Revenue has grown by 8.43% in the last year.
SRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q1000%
Revenue 1Y (TTM)8.43%
Revenue growth 3Y14.62%
Revenue growth 5Y2.41%
Revenue growth Q2Q-0.72%

3.2 Future

The Earnings Per Share is expected to grow by 148.17% on average over the next years. This is a very strong growth
Based on estimates for the next years, SRI will show a small growth in Revenue. The Revenue will grow by 5.17% on average per year.
EPS Next Y278.24%
EPS Next 2Y148.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.91%
Revenue Next 2Y5.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 52.08, SRI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRI indicates a slightly more expensive valuation: SRI is more expensive than 64.29% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SRI to the average of the S&P500 Index (21.49), we can say SRI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 52.08

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.02

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SRI's earnings are expected to grow with 148.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y148.17%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SRI!.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (4/26/2024, 7:17:28 PM)

After market: 15.78 0 (0%)

15.78

+0.43 (+2.8%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap436.63M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.08
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE -1.8%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.78%
PM (TTM) N/A
GM 20.71%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.41
Quick Ratio 1.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y278.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.43%
Revenue growth 3Y14.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y